查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946603

2026年全球神經栓塞器材市場報告

Neurovascular Embolization Devices Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，神經血管栓塞器械的市場規模顯著成長，預計將從2025年的13.8億美元成長到2026年的14.7億美元，複合年成長率為6.2%。過去幾年的成長可歸因於多種因素，例如腦動脈瘤發病率的上升、介入神經放射學手術的普及、熟練的神經血管專科醫生數量的增加、醫院對先進神經科護理投入的增加以及微創卒中治療方法的日益普及。

預計未來幾年，神經血管栓塞器械市場將維持強勁成長，到2030年市場規模將達到19.1億美元，複合年成長率（CAGR）為6.8%。預測期內的成長要素包括：對先進中風治療方案的需求不斷成長、神經血管研發投入增加、血管疾病患者老化加劇、新一代栓塞器械的廣泛應用以及對改善手術效果的日益重視。預測期內的主要趨勢包括：血流晶粒支架的廣泛應用、液體栓塞系統的使用日益普及、微創介入神經放射學介入治療的日益受到青睞、先進塗層彈簧圈技術的推廣以及對精準神經血管器械的日益關注。

出血事件發生率的上升預計將推動神經血管栓塞器械市場擴張。出血是指體內異常且無法控制的出血，或因皮膚或黏膜破損導致的體外異常出血。導致出血事件高發生率的因素包括人口老化、高血壓盛行率上升以及抗凝血劑的廣泛使用。神經血管栓塞器械在治療出血性中風中發揮至關重要的作用，因為它們可以透過阻塞異常血管來控制出血並防止進一步的腦損傷。例如，倫敦國王學院最近的一項研究預測，到2050年，英國70至95歲人群中腦出血（一種特定類型的出血）的病例數和死亡人數將增加59.4%。因此，出血事件的增加趨勢正在推動神經血管栓塞器械市場的成長。

神經血管栓塞器械市場的主要企業正致力於開發先進的解決方案，例如新一代血流導引裝置，以取代傳統的動脈瘤治療方法。新一代血流導向裝置旨在透過提高與血管壁的黏附性、降低血栓風險以及即使在複雜的動脈瘤解剖結構中也能更輕鬆地部署，從而增強手術的安全性和有效性。例如，2025年7月，美國醫療技術公司史賽克(Stryker)宣布推出其神經血管產品組合中的Surpass 精英血流導向裝置。這款創新裝置透過為大型或巨大未破裂腦動脈瘤提供微創血流導向療法，取代了傳統的動脈瘤治療裝置。該產品具有更高的抗血栓性和最佳化的編織設計，使醫生能夠以更少的干涉實現更佳的手術效果。結合史賽克的培訓和醫生支援計劃，該產品可提供無縫的臨床體驗。 Surpass 精英血流導向裝置可提高病患安全性，簡化手術流程，並支持在神經血管手術中更廣泛地採用血流導向療法。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球神經血管栓塞器材市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧和自主智慧
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 血流晶粒支架的應用日益增多
    • 液體栓塞系統的使用日益增多
    • 人們越來越傾向選擇微創介入神經放射學介入治療
    • 擴展先進塗層卷材技術
    • 人們越來越重視精密神經血管裝置

第5章 終端用戶產業市場分析

  • 醫院
  • 門診手術中心
  • 神經科專科診所
  • 神經血管研究所
  • 中風護理中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球神經血管栓塞器械市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球神經血管栓塞器材市場規模、對比及成長率分析
  • 全球神經栓塞器材市場表現：規模與成長，2020-2025年
  • 全球神經栓塞器材市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 栓塞彈簧圈、液體栓塞系統、血流導引支架、動脈瘤夾及其他產品
  • 透過治療
  • 神經血管出血管理，出血性中風治療方案
  • 指示
  • 腦動脈瘤、動靜脈畸形及其他適應症
  • 最終用戶
  • 醫院、門診手術中心和其他最終用戶
  • 依類型細分：栓塞線圈
  • 落葉型線圈、裸鉑線圈、水凝膠塗層線圈
  • 依類型細分：液體栓塞系統
  • 基於N-丁基氰基丙烯酸酯的栓塞材料，Onyx液體栓塞系統
  • 按類型細分：血流導向支架
  • 採用雙層技術的支架，用於治療動脈瘤的血流導向裝置
  • 依類型細分：動脈瘤夾
  • 鈦合金夾子，不銹鋼夾子
  • 按類型細分：其他產品
  • 栓塞球囊、微導管

第10章 區域與國家分析

  • 全球神經栓塞器材市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球神經栓塞器材市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 神經栓塞器材市場：競爭格局及市場佔有率（2024年）
  • 神經栓塞器材市場：公司估值矩陣
  • 神經栓塞器材市場：公司概況
    • Johnson & Johnson
    • Abbott Laboratories
    • Medtronic plc
    • Stryker Corporation
    • Boston Scientific Corporation

第37章：其他領先和創新企業

  • Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年神經栓塞器材市場：提供新機會的國家
  • 2030年神經血管栓塞器材市場：充滿新機會的細分市場
  • 2030年神經栓塞器材市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MNEDM01_G26Q1

Neurovascular embolization devices are medical tools utilized to address irregular blood vessels in the brain or central nervous system by obstructing or altering blood flow. They play a crucial role in neuro-interventional treatments aimed at addressing conditions such as aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas (AVFs) that could lead to bleeding or other adverse outcomes.

The primary products within the category of neurovascular embolization devices comprise embolization coils, liquid embolic systems, flow diversion stents, aneurysm clips, and other related items. Embolization coils, constructed from materials such as platinum or stainless steel, are flexible devices employed to block blood flow within vessels. They are utilized in diverse treatments such as ischemic and hemorrhagic stroke solutions and are indicated for conditions such as brain aneurysms and arteriovenous malformations. These devices are utilized by various end-users including hospitals, ambulatory surgical centers, and others.

Tariffs are impacting the neurovascular embolization devices market by increasing costs of imported platinum coils, nitinol stents, microcatheters, polymers, and precision-manufactured components used in embolization systems. Hospitals and device manufacturers in North America and Europe are most affected due to reliance on specialized imported materials, while Asia-Pacific faces higher costs for device exports and component sourcing. These tariffs are raising device prices and impacting procurement budgets for neurointerventional procedures. However, they are also encouraging localized manufacturing, regional supplier partnerships, and increased investment in domestic production of high-value neurovascular devices.

The neurovascular embolization devices market research report is one of a series of new reports from The Business Research Company that provides neurovascular embolization devices market statistics, including neurovascular embolization devices industry global market size, regional shares, competitors with a neurovascular embolization devices market share, detailed neurovascular embolization devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurovascular embolization devices industry. This neurovascular embolization devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurovascular embolization devices market size has grown strongly in recent years. It will grow from $1.38 billion in 2025 to $1.47 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising prevalence of cerebral aneurysms, expansion of neurointerventional procedures, increasing availability of skilled neurovascular specialists, growing hospital investments in advanced neurocare, wider adoption of minimally invasive stroke treatments.

The neurovascular embolization devices market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for advanced stroke management solutions, rising investments in neurovascular R&D, expansion of aging population with vascular disorders, growing adoption of next-generation embolization devices, increasing focus on improving procedural outcomes. Major trends in the forecast period include increasing adoption of flow diversion stents, rising use of liquid embolic systems, growing preference for minimally invasive neurointerventions, expansion of coil technologies with advanced coatings, enhanced focus on precision neurovascular devices.

The increasing incidence of hemorrhages is anticipated to drive the neurovascular embolization devices market forward. Hemorrhages represent abnormal and uncontrollable bleeding occurring either internally within the body or externally through breaks in the skin or mucous membranes. Factors contributing to the prevalence of hemorrhages include aging populations, heightened occurrences of hypertension, and expanded usage of anticoagulant medications. Neurovascular embolization devices play a crucial role in managing hemorrhagic strokes by blocking abnormal blood vessels, thereby reducing bleeding and averting further brain damage. For example, recent research conducted by King's College London indicates an expected 59.4% increase in cases and deaths from intracerebral hemorrhage (a specific type of hemorrhage) among individuals aged 70 to 95 across the UK by 2050. Consequently, the mounting prevalence of hemorrhages propels the growth of the neurovascular embolization devices market.

Leading companies in the neurovascular embolization devices market are focusing on developing advanced solutions, such as next-generation flow diverters, to replace traditional aneurysm treatment methods. A next-generation flow diverter is a device designed to enhance procedural safety and effectiveness by improving vessel wall apposition, reducing clotting risk, and enabling easier deployment in complex aneurysm anatomies. For example, in July 2025, Stryker Corporation, a US-based medical technology company, launched the Surpass Elite Flow Diverter as part of its neurovascular portfolio. This innovation replaces older aneurysm treatment devices by offering minimally invasive flow diversion therapy for large or giant unruptured intracranial aneurysms. It features improved thrombo-resistance and an optimized braid design, allowing physicians to achieve better procedural outcomes with less manipulation. When integrated with Stryker's training and physician support programs, it provides a seamless clinical experience. The Surpass Elite Flow Diverter enhances patient safety, streamlines procedural workflows, and supports wider adoption of flow diversion therapy in neurovascular care.

In May 2023, Stryker Corporation, a US-based medical technology company, completed the acquisition of Cerus Endovascular Ltd for $530 million. This strategic move by Stryker was aimed at strengthening its expertise in offering innovative medical devices tailored for treating intracranial aneurysms, including products such as the contour neurovascular system and the neqstent coil-assisted flow diverter. Cerus Endovascular Ltd, headquartered in Ireland, specializes in the development of cutting-edge neurovascular embolization devices designed specifically for the treatment of intracranial aneurysms.

Major companies operating in the neurovascular embolization devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH, Cerenovus, Sequent Medical Inc

North America was the largest region in the neurovascular embolization devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurovascular embolization devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurovascular embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neurovascular embolization devices market consists of sales of particle embolic, detachable balloons, vascular plugs, and embolization microspheres. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurovascular Embolization Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neurovascular embolization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurovascular embolization devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurovascular embolization devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Embolization Coils; Liquid Embolic Systems; Flow Diversion Stents; Aneurysm Clips; Other Products
  • 2) By Treatment: Neurovascular Hemorrhage Management; Hemorrhagic Stroke Solutions
  • 3) By Indication: Brain Aneurysms; Arteriovenous Malformation; Other Indications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Embolization Coils: Detachable Coils; Bare Platinum Coils; Coils With Hydrogel Coatings
  • 2) By Liquid Embolic Systems: N-Butyl Cyanoacrylate-Based Embolics; Onyx Liquid Embolic System
  • 3) By Flow Diversion Stents: Stents With Dual-Layer Technology; Flow Diverters For Aneurysm Treatment
  • 4) By Aneurysm Clips: Titanium Clips; Stainless Steel Clips
  • 5) By Other Products: Balloons For Embolization; Microcatheters
  • Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Stryker Corporation; Boston Scientific Corporation; Kaneka Corporation; Terumo Corporation; B Braun Melsungen AG; Cook Medical LLC; Integer Holdings Corporation; Merit Medical Systems Inc; Penumbra Inc; Asahi Intecc Co Ltd; MicroVention Inc; Balt USA LLC; Imperative Care Inc; Acandis GmbH & Co KG; Rapid Medical Ltd; Vesalio LLC; Phenox GmbH; Cerenovus; Sequent Medical Inc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Neurovascular Embolization Devices Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Neurovascular Embolization Devices Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Neurovascular Embolization Devices Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Neurovascular Embolization Devices Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Flow Diversion Stents
    • 4.2.2 Rising Use Of Liquid Embolic Systems
    • 4.2.3 Growing Preference For Minimally Invasive Neurointerventions
    • 4.2.4 Expansion Of Coil Technologies With Advanced Coatings
    • 4.2.5 Enhanced Focus On Precision Neurovascular Devices

5. Neurovascular Embolization Devices Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Specialty Neurology Clinics
  • 5.4 Neurovascular Research Institutes
  • 5.5 Stroke Care Centers

6. Neurovascular Embolization Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neurovascular Embolization Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Neurovascular Embolization Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Neurovascular Embolization Devices Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Neurovascular Embolization Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Neurovascular Embolization Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neurovascular Embolization Devices Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neurovascular Embolization Devices Market Segmentation

  • 9.1. Global Neurovascular Embolization Devices Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, Other Products
  • 9.2. Global Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Neurovascular Hemorrhage Management, Hemorrhagic Stroke Solutions
  • 9.3. Global Neurovascular Embolization Devices Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Brain Aneurysms, Arteriovenous Malformation, Other Indications
  • 9.4. Global Neurovascular Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Other End Users
  • 9.5. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Embolization Coils, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Detachable Coils, Bare Platinum Coils, Coils With Hydrogel Coatings
  • 9.6. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Liquid Embolic Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • N-Butyl Cyanoacrylate-Based Embolics, Onyx Liquid Embolic System
  • 9.7. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Flow Diversion Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Stents With Dual-Layer Technology, Flow Diverters For Aneurysm Treatment
  • 9.8. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Aneurysm Clips, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Titanium Clips, Stainless Steel Clips
  • 9.9. Global Neurovascular Embolization Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Balloons For Embolization, Microcatheters

10. Neurovascular Embolization Devices Market Regional And Country Analysis

  • 10.1. Global Neurovascular Embolization Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Neurovascular Embolization Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neurovascular Embolization Devices Market

  • 11.1. Asia-Pacific Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neurovascular Embolization Devices Market

  • 12.1. China Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neurovascular Embolization Devices Market

  • 13.1. India Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neurovascular Embolization Devices Market

  • 14.1. Japan Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neurovascular Embolization Devices Market

  • 15.1. Australia Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neurovascular Embolization Devices Market

  • 16.1. Indonesia Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neurovascular Embolization Devices Market

  • 17.1. South Korea Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neurovascular Embolization Devices Market

  • 18.1. Taiwan Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neurovascular Embolization Devices Market

  • 19.1. South East Asia Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neurovascular Embolization Devices Market

  • 20.1. Western Europe Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neurovascular Embolization Devices Market

  • 21.1. UK Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neurovascular Embolization Devices Market

  • 22.1. Germany Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neurovascular Embolization Devices Market

  • 23.1. France Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neurovascular Embolization Devices Market

  • 24.1. Italy Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neurovascular Embolization Devices Market

  • 25.1. Spain Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neurovascular Embolization Devices Market

  • 26.1. Eastern Europe Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neurovascular Embolization Devices Market

  • 27.1. Russia Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neurovascular Embolization Devices Market

  • 28.1. North America Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neurovascular Embolization Devices Market

  • 29.1. USA Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neurovascular Embolization Devices Market

  • 30.1. Canada Neurovascular Embolization Devices Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neurovascular Embolization Devices Market

  • 31.1. South America Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neurovascular Embolization Devices Market

  • 32.1. Brazil Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neurovascular Embolization Devices Market

  • 33.1. Middle East Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neurovascular Embolization Devices Market

  • 34.1. Africa Neurovascular Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Neurovascular Embolization Devices Market, Segmentation By Product, Segmentation By Treatment, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neurovascular Embolization Devices Market Regulatory and Investment Landscape

36. Neurovascular Embolization Devices Market Competitive Landscape And Company Profiles

  • 36.1. Neurovascular Embolization Devices Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Neurovascular Embolization Devices Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Neurovascular Embolization Devices Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Neurovascular Embolization Devices Market Other Major And Innovative Companies

  • Kaneka Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical LLC, Integer Holdings Corporation, Merit Medical Systems Inc, Penumbra Inc, Asahi Intecc Co Ltd, MicroVention Inc, Balt USA LLC, Imperative Care Inc, Acandis GmbH & Co KG, Rapid Medical Ltd, Vesalio LLC, Phenox GmbH

38. Global Neurovascular Embolization Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neurovascular Embolization Devices Market

40. Neurovascular Embolization Devices Market High Potential Countries, Segments and Strategies

  • 40.1 Neurovascular Embolization Devices Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Neurovascular Embolization Devices Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Neurovascular Embolization Devices Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer